About Michael Healy
Michael is a PhD student in the Autophagy group within the Cork Cancer Research Centre. His main interests are improving drug therapies to tackle treatment-resistant cancers and the understanding underlying cauase of drug-resistance.
Theme / Team
Autophagy, Cancer Genetics
Michael graduated with a BSc in Biochemistry from University College Cork in 2010 and enrolled in an MSc in Neuropharmacology from National University of Ireland, Galway in 2011. Following this he was awarded a place as a PhD student in the MMI-funded Clinical & Translational Research Scholars Programme (CTRSP).
After a year of laboratory and industrial placements, as well as both taught and self-directed learning modules, Michael began his formal PhD project in the Cork Cancer Research Centre (CCRC), under the supervision of Dr. Sharon McKenna and Prof. Brendan Buckley. His project, "Investigation into the role of autophagy in chemo-resistant cancers" is looking at the role of the cell death/survival mechanism, autophagy, in the treatment of poor-prognosis cancers, such as oesophageal cancer. As part of his project he is evaluating the benefit of different drug combinations in tackling drug-resistant oesophageal cancer. His research goals also includes identifying novel genes responsible for the modulation of drug resistance.